These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2002748)
21. Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase. Melamed E; Youdim MB Br J Pharmacol; 1985 Nov; 86(3):529-31. PubMed ID: 3877535 [TBL] [Abstract][Full Text] [Related]
22. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier. Riachi NJ; Harik SI Life Sci; 1988; 42(23):2359-63. PubMed ID: 3259663 [TBL] [Abstract][Full Text] [Related]
23. Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents. Fuller RW; Steranka LR Life Sci; 1985 Jan; 36(3):243-7. PubMed ID: 3871244 [TBL] [Abstract][Full Text] [Related]
24. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor. Sagi Y; Weinstock M; Youdim MB J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570 [TBL] [Abstract][Full Text] [Related]
25. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice. Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514 [TBL] [Abstract][Full Text] [Related]
26. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity. Arai Y; Toyoshima Y; Kinemuchi H; Tadano T; Kisara K Neurosci Lett; 1986 Oct; 70(2):266-71. PubMed ID: 3490638 [TBL] [Abstract][Full Text] [Related]
27. Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco. Castagnoli KP; Steyn SJ; Petzer JP; Van der Schyf CJ; Castagnoli N Chem Res Toxicol; 2001 May; 14(5):523-7. PubMed ID: 11368550 [TBL] [Abstract][Full Text] [Related]
28. Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):147-56. PubMed ID: 3496637 [TBL] [Abstract][Full Text] [Related]
29. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694 [TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke. Khalil AA; Davies B; Castagnoli N Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520 [TBL] [Abstract][Full Text] [Related]
31. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B. Fritz RR; Abell CW; Patel NT; Gessner W; Brossi A FEBS Lett; 1985 Jul; 186(2):224-8. PubMed ID: 3874094 [TBL] [Abstract][Full Text] [Related]
32. Difference in monoamine oxidase B activity between C57 black and albino NMRI mouse strains may explain differential effects of the neurotoxin MPTP. Zimmer J; Geneser FA Neurosci Lett; 1987 Aug; 78(3):253-8. PubMed ID: 3498133 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke. Méndez-Alvarez E; Soto-Otero R; Sánchez-Sellero I; López-Rivadulla Lamas M Life Sci; 1997; 60(19):1719-27. PubMed ID: 9129127 [TBL] [Abstract][Full Text] [Related]
34. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline. Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878 [TBL] [Abstract][Full Text] [Related]
35. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A. Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758 [TBL] [Abstract][Full Text] [Related]
36. Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase B. Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC J Neurochem; 1985 Oct; 45(4):1049-54. PubMed ID: 3928814 [TBL] [Abstract][Full Text] [Related]
37. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Itzhak Y; Mash D; Zhang SH; Stein I Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660 [TBL] [Abstract][Full Text] [Related]
38. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151 [TBL] [Abstract][Full Text] [Related]
39. Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains. Riachi NJ; Behmand RA; Harik SI Brain Res; 1991 Jul; 555(1):19-24. PubMed ID: 1933326 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Youngster SK; Sonsalla PK; Heikkila RE J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]